|
CCDC99 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.54143406109142E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.4586998275945E-10 |
| Normal-vs-Stage2 |
1.339460E-03 |
| Normal-vs-Stage3 |
1.54985999999413E-05 |
| Normal-vs-Stage4 |
5.431400E-04 |
| Stage1-vs-Stage2 |
8.610200E-01 |
| Stage1-vs-Stage3 |
9.929000E-01 |
| Stage1-vs-Stage4 |
1.234570E-01 |
| Stage2-vs-Stage3 |
8.865600E-01 |
| Stage2-vs-Stage4 |
1.414240E-01 |
| Stage3-vs-Stage4 |
1.421990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52310386525301E-11 |
| Normal-vs-AfricanAmerican |
7.020500E-03 |
| Normal-vs-Asian |
8.979500E-02 |
| Caucasian-vs-AfricanAmerican |
1.467610E-01 |
| Caucasian-vs-Asian |
2.840000E-01 |
| AfricanAmerican-vs-Asian |
1.978830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.08289999189992E-09 |
| Normal-vs-Female |
2.08499995046907E-09 |
| Male-vs-Female |
7.432600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.637800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.80729999854634E-08 |
| Normal-vs-Age(61-80Yrs) |
3.15379999893395E-09 |
| Normal-vs-Age(81-100Yrs) |
1.074150E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.592200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.263600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.608840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.592400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.238400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.119000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.021100E-04 |
| Normal-vs-Grade 2 |
2.66600075349288E-11 |
| Normal-vs-Grade 3 |
8.11599998318258E-09 |
| Normal-vs-Grade 4 |
2.159600E-03 |
| Grade 1-vs-Grade 2 |
9.947200E-01 |
| Grade 1-vs-Grade 3 |
5.474800E-01 |
| Grade 1-vs-Grade 4 |
2.074600E-01 |
| Grade 2-vs-Grade 3 |
3.191800E-01 |
| Grade 2-vs-Grade 4 |
1.867000E-01 |
| Grade 3-vs-Grade 4 |
1.170240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.06520381193809E-11 |
| Normal-vs-ccB subtype |
7.25170000048792E-07 |
| ccA subtype-vs-ccB subtype |
7.273800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.79150000179496E-08 |
| Normal-vs-N1 |
6.220300E-02 |
| N0-vs-N1 |
4.328400E-01 |
|
|
